Get started
Author

Jeffery D. Zwicker

Observed name: J. Zwicker
ORCID: 0000-0002-3926-3647
Observed ORCID: 0000-0002-3926-3647
OpenAlex ID: A5012915911
System X−c Antiporter Inhibitors: Azo-Linked Amino-Naphthyl-Sulfonate Analogues of Sulfasalazine
2019 · M. Nehser, J. Dark, et al. · Neurochemical Research · 21
PDF
Optimization of dipeptidic inhibitors of cathepsin L for improved Toxoplasma gondii selectivity and CNS permeability
2018 · Jeffery D. Zwicker, Nicolas A. Diaz, et al. · Bioorganic & Medicinal Chemistry Letters · 20
Discovery and Optimization of Triazine Nitrile Inhibitors of Toxoplasma gondii Cathepsin L for the Potential Treatment of Chronic Toxoplasmosis in the CNS
2020 · Jeffery D. Zwicker, David Smith, et al. · ACS Chemical Neuroscience · 17
Abstract 4045: DCC-3084, a RAF dimer inhibitor, broadly inhibits BRAF class I, II, III, BRAF fusions, and RAS-driven solid tumors leading to tumor regression in preclinical models
2023 · Stacie L. Bulfer, Bertrand Le Bourdonnec, et al. · Cancer Research · 4
Abstract 4938: DP-9024, an investigational small molecule modulator of the integrated stress response kinase GCN2, synergizes with asparaginase therapy in leukemic tumors
2023 · Gada Al-Ani, Kristin M. Elliott, et al. · Cancer Research · 2
Inhibition of the Vesicular Glutamate Transporter (VGLUT) with Congo Red Analogs: New Binding Insights
2021 · David M. Hitt, Jeffery D. Zwicker, et al. · Neurochemical Research · 2
Abstract 1639: DP-9149, an investigational small molecule modulator of the Integrated Stress Response kinase GCN2, pre-clinically causes solid tumor growth inhibition as a single agent and regression in combination with standard of care agents
2023 · Gada Al-Ani, Qi Groer, et al. · Cancer Research · 1
Abstract 5743: Discovery of a novel orally available microtubule-destabilization agent that targets the colchicine binding site and exhibits antitumor activity in KRAS -mutant models
2026 · Yeni K. Romero, Joshua W. Large, et al. · Cancer Research
Abstract 408: Discovery of a first-in-class dual microtubule- and RAF—targeting inhibitor.
2026 · Joshua W. Large, Yeni K. Romero, et al. · Cancer Research
Abstract 1613: Dimerization-induced activation of the integrated stress response kinase PERK by an investigational small molecule modulator, DP-9024
2023 · Gada Al-Ani, Aaron J. Rudeen, et al. · Cancer Research
Abstract 1640: DP-9024, an investigational small molecule modulator of the Integrated Stress Response kinase PERK, causes B-cell cancer growth inhibition as single agent and in combination with standard-of-care agents
2023 · Gada Al-Ani, Qi Groer, et al. · Cancer Research
Development of CNS Penetrant Inhibitors of Toxoplasma Gondii Cathepsin L
2018 · Jeffery D. Zwicker · Deep Blue (University of Michigan)
PDF
Works count: 12
Citation count: 67
H-index: 4
I10-index: 3
Year
Topic
Type